The FAK‐NRF2 Axis Alleviates DOX‐Induced Cardiotoxicity by Inhibiting Ferroptosis
The FASEB Journal · 2025
DOI: 10.1096/fj.202501368r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Ying Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Ferroptosis, Doxorubicin, Cardiotoxicity. Die Arbeit nennt 68 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Chinese Academy of Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Doxorubicin (DOX), a prevalent anthracycline chemotherapeutic agent, is associated with considerable cardiotoxicity, the molecular mechanisms of which remain incompletely understood. Focal adhesion kinase (FAK), a non‐receptor protein tyrosine kinase, plays a crucial role in cardiac survival signaling during both developmental and pathological stress conditions. In this study, we demonstrate that FAK overexpression in SKOV3 mice and AC16 cardiomyocytes ameliorates DOX‐induced cardiomyopathy by inhibiting ferroptosis. Mechanistically, DOX treatment induces ferroptosis in cardiomyocytes by suppressing FAK activity. Furthermore, we reveal that FAK overexpression reduces DOX cardiotoxicity, at least in part, through the upregulation of the transcription factor Nuclear factor erythroid 2‐related factor 2 (NRF2). The protective effects of FAK against myocardial injury are nullified by NRF2 knockdown. Additionally, histone deacetylase 5 (HDAC5) may be involved in this protective pathway. These findings identify FAK as a critical regulator of DOX‐induced cardiotoxicity and suggest that enhancing the FAK/NRF2/HDAC5 signaling axis in cardiac tissue could represent a promising strategy for preserving myocardial function in patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
- Laboratory of Anesthesia and Perioperative Medicine, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
- Department of Physiology, Naval Medical University, Shanghai, China.
ORCID-Profile: Xiaoyan Zhu, Pingbo Xu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Zhao, Y., Chen, M., Kong, L., Wu, S., Teng, C., Hu, S., Xie, K., Du, J., Zhu, X., Wang, P., & Xu, P. (2025). The FAK‐NRF2 Axis Alleviates DOX‐Induced Cardiotoxicity by Inhibiting Ferroptosis. The FASEB Journal. https://doi.org/10.1096/fj.202501368r
Vancouver
Zhao Y, Chen M, Kong L, Wu S, Teng C, Hu S, et al. The FAK‐NRF2 Axis Alleviates DOX‐Induced Cardiotoxicity by Inhibiting Ferroptosis. The FASEB Journal. 2025. doi:10.1096/fj.202501368r
BibTeX
@article{Zhao2025,
author = {Zhao, Ying and Chen, Mo and Kong, Linghui and Wu, Shufei and Teng, Cheng and Hu, Song and Xie, Kangjie and Du, Jiankui and Zhu, Xiaoyan and Wang, Pengxiang and Xu, Pingbo},
title = {The FAK‐NRF2 Axis Alleviates DOX‐Induced Cardiotoxicity by Inhibiting Ferroptosis},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202501368r}
}
EUVIMED